Katherine Ruffner's most recent trade in Cardiff Oncology Inc was a trade of 170,016 Stock Options done . Disclosure was reported to the exchange on March 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiff Oncology Inc | Katherine Ruffner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 170,016 | 370,016 | - | - | Stock Options | |
| Cardiff Oncology Inc | Katherine Ruffner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2021 | 200,000 | 200,000 | - | - | Stock Options |